Azatadine - CAS 3964-81-6
Catalog number: 3964-81-6
Category: Inhibitor
Not Intended for Therapeutic Use. For research use only.
Molecular Formula:
C20H22N2
Molecular Weight:
290.40
COA:
Inquire
Targets:
Histamine Receptor
Description:
Azatadine is a new antihistamine acts as histamine for histamine H1- receptor inhibitor ( IC50 = 6.5 nM and 10 nM, respectively).
Publictions citing BOC Sciences Products
  • >> More
Purity:
≥98%
Appearance:
Solid powder
Synonyms:
6,11-Dihydro-11-(1-methyl-4-piperidylidene)-5H-benzo[5,6]cyclohepta-[1,2-b]pyridine; 2-(1-methylpiperidin-4-ylidene)-4-azatricyclo[9.4.0.0³,⁸]pentadeca-1(15),3(8),4,6,11,13-hexaene;
Solubility:
Soluble in DMSO
Storage:
Store at -20 °C
MSDS:
Inquire
Application:
Antihistaminic.
Quality Standard:
Enterprise Standard
Shelf Life:
As supplied, 2 years from the QC date provided on the Certificate of Analysis, when stored properly
Quantity:
Milligrams-Grams
Melting Point:
124-126 °C
Density:
1.127
InChIKey:
SEBMTIQKRHYNIT-UHFFFAOYSA-N
InChI:
1S/C20H22N2/c1-22-13-10-16(11-14-22)19-18-7-3-2-5-15(18)8-9-17-6-4-12-21-20(17)19/h2-7,12H,8-11,13-14H2,1H3
Canonical SMILES:
CN1CCC(CC1)=C1C2=CC=CC=C2CCC2=C1N=CC=C2
Current Developer:
Schering-Plough
1.Syntheses of molecularly imprinted polymers: Molecular recognition of cyproheptadine using original print molecules and azatadine as dummy templates.
Feás X1, Seijas JA, Vázquez-Tato MP, Regal P, Cepeda A, Fente C. Anal Chim Acta. 2009 Jan 12;631(2):237-44. doi: 10.1016/j.aca.2008.10.054. Epub 2008 Oct 31.
The use of custom-made polymeric materials with high selectivities as target molecules in solid-phase extraction (SPE), known as molecularly imprinted solid-phase extraction (MISPE), is becoming an increasingly important sample preparation technique. However, the potential risk of leakage of the imprinting molecules during the desorption phase has limited application. The use of a mimicking template, called a dummy molecular imprinting polymer (DMIP), that bears the structure of a related molecule and acts as a putative imprinting molecule may provide a useful solution to this problem. In the current study, cyproheptadine (CPH) and azatadine (AZA) were used as templates in the development of an MIP and DMIP for acrylic acid and methacrylic acid monomers. Our results indicate that DMIPs have equal recognition of CPH, avoiding the problem of leakage of original template during the desorption phase relative to MIPs synthesized in presence of the print molecule CPH.
2.Antiallergic effects of H1-receptor antagonists.
Baroody FM1, Naclerio RM. Allergy. 2000;55 Suppl 64:17-27.
The primary mechanism of antihistamine action in the treatment of allergic diseases is believed to be competitive antagonism of histamine binding to cellular receptors (specifically, the H1-receptors), which are present on nerve endings, smooth muscles, and glandular cells. This notion is supported by the fact that structurally unrelated drugs antagonize the H1-receptor and provide clinical benefit. However, H1-receptor antagonism may not be their sole mechanism of action in treating allergic rhinitis. On the basis of in vitro and animal experiments, drugs classified as H1-receptor antagonists have long been recognized to have additional pharmacological properties. Most first-generation H1-antihistamines have anticholinergic, sedative, local anaesthetic, and anti-5-HT effects, which might favourably affect the symptoms of the allergic response but also contribute to side-effects. These additional properties are not uniformly distributed among drugs classified as H1-receptor antagonists.
3.Application of dummy molecularly imprinted solid-phase extraction in the analysis of cyproheptadine in bovine urine.
Feás X1, Ye L, Regal P, Fente CA, Hosseini SV, Cepeda A. J Sep Sci. 2009 May;32(10):1740-7. doi: 10.1002/jssc.200800726.
Due to the difficulty of monitoring trace levels of cyproheptadine (CYP) residues in complicated biological matrices, specific adsorption materials for the preconcentration and clean-up of CYP are indispensable. In this work, CYP was extracted from urine using dummy molecularly imprinted SPE (DMISPE) to avoid leakage of the imprinting molecules during the desorption phase. For synthesis of DMISPE, azatadine (AZA) was employed as the dummy template, methacrylic acid (MAA) as the monomer, ethylene glycol dimethacrylate (EGDMA) as the cross-linker, 2,2'-azobis(2-methylpropionitrile) (AIBN) as the initiator, and dichloromethane as the porogen solvent. An LC-MS/MS method was used to analyze CYP. Two MRM (multiple reaction monitoring) transitions for each analyte were monitored using diphenylpyraline hydrochloride (DPP.HCl), which was used as an internal standard. The advantages of DMISPE include obtaining less complex chromatograms and reducing ion suppression in ESI.
4.Interaction between chloroquine and diverse pharmacological agents in chloroquine resistant Plasmodium yoelii nigeriensis.
Singh N1, Puri SK. Acta Trop. 2000 Nov 2;77(2):185-93.
The effect of a number of pharmacological agents on the enhancement of antimalarial activity of chloroquine was evaluated against chloroquine resistant line of Plasmodium yoelii nigeriensis (N-67). The response after combination therapy was monitored on the basis of alteration in the course of parasitaemia, the extension of mean survival time and the percent cure rate in different groups. The study was designed to compare the in vivo efficacy of a number of resistance modulating agents found effective in several in vitro studies against chloroquine resistant P. falciparum isolates. Based on their efficacy in this rodent model, the response of combination of chloroquine with agents representing diverse chemical moieties has been categorised as curative, moderately active and inactive. Out of the 22 agents evaluated, only cyproheptadine-chloroquine combination produced curative response. Ketotifen, azatadine, pheniramine, amitriptyline, fluoxetine, verapamil, penfluridol and trifluoperazine demonstrated moderate activity while loratadine, terfenadine, promethazine, ranitidine, nifedipine, diltiazem, chlorpromazine, amiodarone, tamoxifen, dipyridamol, propranolol, acyclovir and amantidine were inactive.
Molecular Weight Calculator Molarity Calculator Solution Dilution Calculator

Related Histamine Receptor Products


CAS 87233-62-3 Emedastine Difumarate

Emedastine Difumarate
(CAS: 87233-62-3)

Emedastine is a H1 receptor antagonist. It is a second generation antihistamine. Emedastine can block the action of histamine that causes allergic symptoms. It ...

CAS 82-93-9 Chlorcyclizine

Chlorcyclizine
(CAS: 82-93-9)

Chlorcyclizine is a first-generation Histamine Receptor antagonist of the phenylpiperazine class. It can be used primarily to treat allergy symptoms such as rhi...

CAS 100643-71-8 Desloratadine

Desloratadine
(CAS: 100643-71-8)

Desloratadine is a potent antagonist for human histamine H1 receptor with IC50 of 51 nM.

CAS 3978-86-7 Azatadine dimaleate

Azatadine dimaleate
(CAS: 3978-86-7)

Azatadine is an histamine and cholinergic inhibitor with IC50 of 6.5 nM and 10 nM, respectively.

CAS 147-24-0 Diphenhydramine HCl

Diphenhydramine HCl
(CAS: 147-24-0)

Diphenhydramine HCl (Benadryl), a histamine H1 antagonist used as an antiemetic, antitussive, for dermatoses and pruritus, for hypersensitivity reactions, as a ...

CAS 202189-78-4 Bilastine

Bilastine
(CAS: 202189-78-4)

Bilastine is a novel, nonsedating H1-antihistamine developed for symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria.

CAS 113-92-8 Chlorpheniramine Maleate

Chlorpheniramine Maleate
(CAS: 113-92-8)

Chlorpheniramine inhibits the proliferation of MCF-7, MDA-MB 231, and Ehrlich cells in a dose-response manner, and significantly reduces the ornithine decarboxy...

CAS 51481-61-9 Cimetidine

Cimetidine
(CAS: 51481-61-9)

Cimetidine, a histamine congener, competitively inhibits histamine binding to histamine H2 receptors.

CAS 79794-75-5 Loratadine

Loratadine
(CAS: 79794-75-5)

Loratadine is a histamine H1 receptor antagonist, used to treat allergies. It also acts as a selective inhibitor of B(0)AT2 with IC50 of 4 μM.

GS-283
(CAS: 149440-36-8)

GS-283, an isoquinolin derivative, has been found to be histamine receptor and muscarinic receptor blocker.

CAS 76239-32-2 KP136

KP136
(CAS: 76239-32-2)

KP136, an antiallergic agent, remarkably inhibited the passive cutaneous anaphylaxis (PCA) with intravenous and oral dosing. KP-136 is an oral potent inhibitor ...

CAS 108612-45-9 Mizolastine

Mizolastine
(CAS: 108612-45-9)

Mizolastine is a histamine H1-receptor antagonist with IC50 of 47 nM used in the treatment of hay fever (seasonal allergic rhinitis), hives and other allergic r...

CAS 154-69-8 Tripelennamine hydrochloride

Tripelennamine hydrochloride
(CAS: 154-69-8)

Tripelennamine hydrochloride, the hydrochloride salt form of tripelennamine, is a blood-brain barrier penetrant and orally active H1-receptor antagonist. Tripel...

CAS 58-73-1 Diphenhydramine

Diphenhydramine
(CAS: 58-73-1)

Diphenhydramine is a histamine H1 antagonist. t competitively inhibits the histamine-1 (H1) receptor, thereby alleviating the symptoms caused by endogenous hist...

CAS 5579-84-0 Betahistine dihydrochloride

Betahistine dihydrochloride
(CAS: 5579-84-0)

Betahistine is a histamine H3 receptors inhibitor with IC50 of 1.9 μM.

CAS 59-33-6 Pyrilamine maleate salt

Pyrilamine maleate salt
(CAS: 59-33-6)

Pyrilamine maleate salt is a first generation antihistamine and binds with high affinity to G(q/11) protein. It is commonly utilized as a radioligand binding as...

CAS 87848-99-5 Acrivastine

Acrivastine
(CAS: 87848-99-5)

Acrivastine, also known as BW825C, is an antihistamine with peripheral H1-antagonist potency equal to that of triprolidine for the treatment of allergic rhiniti...

Famotine hydrochloride
(CAS: 10500-82-0)

Famotine hydrochloride is a histamine H2 receptor antagonist. lt has no effect on the cytochrome P450 enzyme system, and does not appear to interact with other ...

Irdabisant
(CAS: 1005402-19-6)

Irdabisant is a potent, selective histamine H3 receptor inverse agonist. It displayed potent antagonist and inverse agonist activities in [³⁵S]guanosine 5'-O-(γ...

SUVN-G3031 hydrochloride
(CAS: 1394808-20-8)

SUVN-G3031 is a Histamine H3 receptor antagonist originated by Suven Life Sciences. Blockade of Histamine H3 receptor can augment the pre-synaptic release of bo...

Chemical Structure

CAS 3964-81-6 Azatadine

Quick Inquiry

Verification code

Featured Items